Delivery Order SPE2DB25D3008-SPE2DB25FRDAA
- Not listed
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,756.32 firm fixed price delivery order for TUKYSA 150 MG tablets (120 count units) on August 18, 2025, with completion scheduled for September 9, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,846.58 delivery order to AmerisourceBergen Drug Corp for 60 tablets of TUKYSA 50 mg on August 8, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $12.7K delivery order to AmerisourceBergen Drug Corp for 60 tablets of TUKYSA 150 mg on August 18, 2025, with completion by September 9, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA is a specialty oncology medication, reflecting the pharmaceutical distributor's role in supplying critical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TUKYSA 150 MG TABLET UU 120S. The award, valued at $12,273.50, has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical supplies, and related distribution services...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug TUKYSA 150 MG TABLET, a specialty medication, with a ceiling value of $25,395.38 and a period of performance through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TUKYSA 150 MG TABLET, a pharmaceutical product, with a ceiling value of $15,756.32. The contract is a firm fixed-price, non-set-aside delivery order, with a period of performance ending on May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $6,125.65 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TUKYSA 150 MG TABLET. The contract has a completion date of February 21, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, as a prime contractor, has a long-standing relationship with DLA Troop Support Medical, providing a wide range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $36,820.50 firm fixed-price contract is for the delivery of the pharmaceutical product TUKYSA 150 MG TABLET UU 120S, with a completion date of October 7, 2024. The contract is not set aside for any specific business type. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, supporting various agencies and...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDAADelivery Order
The Defense Logistics Agency awarded a $15,756.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a prescription oncology medication. This delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 8/19/25 |